About
Technology
Issues
FAQ
Links
Official Page
Efficacy and tolerability of lisdexamfetamine dimesylate (NRP-104) in children with attention-deficit/hyperactivity disorder: A Phase III, multicenter, randomized, double-blind, forced-dose, parallel-group study
Distribution of the number of citations over years.
site/software ©
exaly
; All materials licenced under
CC by-SA
.